Researchers at Detroit-based Karmanos Cancer Institute are harnessing robotic technology to accelerate the search for more effective pancreatic ...
Discover Immuneering’s latest breakthrough: atebimetinib delivers unprecedented survival rates in first-line pancreatic cancer.
VANCOUVER, Washington, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ...
Trump wants to cut the NIH budget by 40 percent. But a new paper found that more than half of drugs approved since 2000 are linked to research that likely wouldn’t have been funded if such a budget ...
Accuray Incorporated ( NASDAQ: ARAY) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT ...
Dear Shareholders, As this pivotal year continues to take shape for CytoDyn Inc. ("CytoDyn" or the "Company"), I am pleased to share the progress ...
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections ...
A new clinical trial report finds that stereotactic radiation therapy offers long-term survival outcomes comparable to surgery for patients with small, early-stage non-small cell lung cancer (NSCLC).
The Chosun Ilbo on MSN
Lung Cancer Pioneer Publicly Battles Stage 4 to Inspire Hope
A world-renowned lung cancer expert has belatedly revealed that he was diagnosed with lung cancer three years ago. The ...
In tissue biopsies, cancer cells are frequently observed to have nuclei (the cell's genetic information storage) that are ...
Cancer immunotherapy and chemotherapy are at the forefront of modern cancer treatment, offering significant advancements over traditional methods. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback